Submit a utility to the registry.

Filter results using search terms, or by selecting one or more valuation, condition, or population.

Viewing 31 - 40 of 44 results
Title   Year(s) of data collection   Valuation Method   Country   Condition  
Selection of neurological disease health state utilities (Lacy B et al., Clin Park Relat Disord. 2023. doi:10.1016/j.prdoa.2022.100180) 2010 - 2011 EQ-5D United States of America Parkinson's disease
DOI
10.7910/DVN/VJSSSX
Author(s)
Registry, Utilities
Description
Health state utilities for neurological disease conditions
Sample Characteristics
A cross-sectional study of 124 patients with PD at an academic movement clinic
Title
Selection of oncology health state utilities (Katanyoo K et al., Expert Rev Pharmacoecon Outcomes Res. 2022. doi:10.1080/14737167.2021.1906224)
Year(s) of data collection
2019
Valuation Method
EQ-5D-3L, EQ-5D-5L, TTO
Country
Thailand
Condition
Cervical cancer
DOI
10.7910/DVN/L4V2LU
Author(s)
Registry, Utilities
Description
Health state utilities for oncology conditions
Sample Characteristics
194 cross-sectional study patients with locally advanced cervical cancer
Title
Selection of oncology health state utilities (Chu YR et al., Integr Cancer Ther. 2023. doi:10.1177/15347354221150907)
Year(s) of data collection
2018 - 2019
Valuation Method
EQ-5D
Country
Taiwan (Province of China)
Condition
Breast cancer
DOI
10.7910/DVN/L4V2LU
Author(s)
Registry, Utilities
Description
Health state utilities for oncology conditions
Sample Characteristics
450 breast cancer patients treated with and without adjunctive traditional Chinese medicine
Title
Selection of oncology health state utilities (Konara Mudiyanselage SP et al., Breast Cancer. 2023. doi:10.1007/s12282-022-01413-6)
Year(s) of data collection
2010 - 2021
Valuation Method
EQ-5D
Country
Taiwan (Province of China)
Condition
Breast cancer surgery
DOI
10.7910/DVN/L4V2LU
Author(s)
Registry, Utilities
Description
Health state utilities for oncology conditions
Sample Characteristics
A cohort of 741 women who underwent a mastectomy and breast reconstruction
Title
Selection of oncology health state utilities (Clavo B et al., Int J Environ Res Public Health. 2023. doi:10.3390/ijerph20021479)
Year(s) of data collection
2019 - 2022
Valuation Method
EQ-5D-5L
Country
Spain
Condition
Symptomatic Cancer Survivor
DOI
10.7910/DVN/L4V2LU
Author(s)
Registry, Utilities
Description
Health state utilities for oncology conditions
Sample Characteristics
26 patients with persistent or refractory side effects of cancer treatments to investigate the effects of ozone treatment
Title
Selection of oncology health state utilities (Cooper OAE et al., Pharmacoecon Open. 2023. doi:10.1007/s41669-023-00392-4)
Year(s) of data collection
2021
Valuation Method
EQ-5D-5L
Country
United Kingdom of Great Britain and Northern Ireland
Condition
Invasive bladder cancer
DOI
10.7910/DVN/L4V2LU
Author(s)
Registry, Utilities
Description
Health state utilities for oncology conditions
Sample Characteristics
202 individuals from UK general public
Title
Selection of oncology health state utilities (Yang M et al., Value Health. 2023. doi:10.1016/j.jval.2023.02.00)
Year(s) of data collection
2016 - 2021
Valuation Method
EQ-5D-5L
Country
Austria, Belgium, China, France, Germany, Israel, Italy, Japan, Korea (Republic of), Netherlands, Poland, Spain, Switzerland, Taiwan (Province of China), United States of America
Condition
Lung cancer
DOI
10.7910/DVN/L4V2LU
Author(s)
Registry, Utilities
Description
Health state utilities for oncology conditions
Sample Characteristics
273 patients with non-small cell lung cancer harboring MET exon 14 skipping treated with tepotinib
Title
Selection of orthopedic and musculoskeletal health state utilities (Kontodimopoulos N et al., J Clin Med. 2022. doi:10.3390/jcm11144097)
Year(s) of data collection
2020
Valuation Method
EQ-5D-3L, EQ-5D-5L, SF-6D
Country
Greece
Condition
Ankylosing spondylities, Musculoskeletal disorders, Osteopenia/Osteporosis, Psoriaticc arthritis, Rheumatiod arthritis
DOI
10.7910/DVN/VR4XYO
Author(s)
Registry, Utilities
Description
Health state utilities for orthopedic and musculoskeletal conditions
Sample Characteristics
A cross-sectional sample of 315 (total) consecutive patients clinically diagnosed with RA, PsA, AS, or OsP/OP
Title
Selection of orthopedic and musculoskeletal health state utilities (Li N et al., J Med Econ. 2022. doi:10.1080/13696998.2022.2087409)
Year(s) of data collection
2014 - 2016
Valuation Method
EQ-5D-5L, SF-6D
Country
Netherlands
Condition
Fracture
DOI
10.7910/DVN/VR4XYO
Author(s)
Registry, Utilities
Description
Health state utilities for orthopedic and musculoskeletal conditions
Sample Characteristics
499 participants in a prospective observational study in a Dutch Fracture Liaison Service clinic
Title
Selection of orthopedic and musculoskeletal health state utilities (Hustedt JW et al., J Hand Surg Am. 2023. doi:10.1016/j.jhsa.2022.11.021)
Year(s) of data collection
2020 - 2021
Valuation Method
EQ-5D
Country
United States of America
Condition
Thumb carpometacarpal arthritis
DOI
10.7910/DVN/VR4XYO
Author(s)
Registry, Utilities
Description
Health state utilities for orthopedic and musculoskeletal conditions
Sample Characteristics
A prospective clinical trial of 48 participants comparing denervation with suspension arthroplasty for treatment of carpometacarpal arthritis of the thumb